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Abstract.  Myo2p is an unconventional myosin re- 
quired for polarized growth in Saccharomyces 
cerevisiae.  Four lines of evidence suggest that (a) 
Myo2p is a target of calmodulin at sites of cell 
growth, and (b) the interaction between Myo2p and 
calmodulin is Ca  ~+ independent.  First,  as assessed by 
indirect immunofluorescence, the distributions of 
Myo2p and calmodulin are nearly indistinguishable 
throughout the cell cycle. Second, a genetic analysis 
indicates that mutations in CMD1 show allele-specific 
synthetic lethality with the myo2-66 conditional muta- 
tion.  Mutations that inactivate the Ca2+-binding  sites 
of calmodulin have little or no effect on strains  carry- 
ing myo2-66,  whereas an allele with a mutation out- 
side the Ca~+-binding  sites dramatically increases the 
severity of the phenotype conferred by myo2-66. 
Third,  Myo2p coimmunoprecipitates with calmodulin 
in the presence of Ca  :+ or EGTA.  Finally,  we used 
a modified gel overlay assay to demonstrate direct 
interaction between calmodulin and fusion proteins 
containing portions of Myo2p. Calmodulin binds 
specifically to the region of Myo2p containing  six tan- 
dem repeats of a motif called an IQ site.  Binding oc- 
curs in either Ca:* or EGTA, and only two sites are 
required to observe binding. 
STABLISHING and maintaining  cell polarity is of fun- 
damental  importance in biology.  Neuron function, 
embryo development,  cell movement,  and yeast cell 
growth all depend on an asymmetric distribution  of cellular 
components.  Within  most nerve cells,  information,  in the 
form of electrical activity, flows in a predictable and consis- 
tent  direction  from the dendrites  and cell body along  the 
axon to presynaptic release sites in the axon terminal (Kandel 
et al.,  1991). Synaptic  vesicles move along precisely orga- 
nized cytoskeletal filaments to their appropriate destinations 
(for review see Portier,  1992). During development,  the dis- 
tribution of yolk protein within the egg cytoplasm influences 
the pattern of embryonic cleavage and defines the animal and 
vegetal poles (Gilbert,  1988).  In the budding  yeast, Sac- 
charomyces cerevisiae, bud site position and the direction of 
bud growth are defined by the polarized arrangement  of the 
actin cytoskeleton (Adams and Pringle,  1984; Kilmartin and 
Adams,  1984). Unlike in more complicated organisms,  it is 
possible in yeast to genetically dissect the pathways that lead 
to the development of cell polarity and thereby define the mo- 
lecular mechanisms underlying  this process. 
Budding in S. cerevisiae consists of several steps: bud site 
selection,  bud site assembly, cytoskeleton organization,  and 
polarized  growth.  Proper  bud  site  selection  requires  the 
function of all five BUD genes. The bud site assembly genes, 
CDC24, CDC42, CDC43, BEM1, and BEM2, are needed to 
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assemble cytoskeletal components at the bud site to direct 
future bud formation and growth. Bud growth occurs by the 
localized fusion of secretory vesicles with the cell surface. 
Secretory vesicles are thought to be transported on an asym- 
metrically arranged  actin-based  cytoskeleton which extends 
from the mother cell towards the bud (for review see Drubin, 
1991; Madden et al., 1992). A recently identified unconven- 
tional myosin, Myo2p, is a putative motor protein implicated 
in transporting  vesicles to the bud along actin cables (John- 
ston et al.,  1991). 
Our  recent  studies  indicate  that  calmodulin  is  also re- 
quired for polarized growth in yeast.  Under nonpermissive 
conditions,  a  temperature-sensitive  calmodulin  mutant  is 
delayed in bud emergence and bud growth although  RNA 
and DNA synthesis proceed at normal rates  (Davis,  1992). 
The accumulation  of calmodulin  at sites of cell growth also 
implicates calmodulin  in polarized growth (Brockerhoff and 
Davis, 1992). Indirect immunofluorescence  studies revealed 
that calmodulin  and actin distributions  overlap  throughout 
the cell cycle. Calmodulin  concentrates  at the presumptive 
bud site in an unbudded cell, at the tip in a growing bud, and 
in the neck region between mother and bud during cytokine- 
sis.  Calmodulin  also accumulates  at the shmoo tip in cells 
treated  with mating pheromone.  Interestingly,  calmodulins 
mutated in the Ca2÷-binding sites  support bud growth and 
localize similarly  to wild-type calmodulin.  Thus,  the func- 
tion of calmodulin  during polarized growth does not depend 
on a high affinity for Ca  2+. 
This  study investigates  the potential  physical  interaction 
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MY02 was identified in a genetic screen for yeast cells that 
increase in mass in the absence of continued proliferation. 
A  strain  containing  the  temperature-sensitive  mutation 
myo2-66 accumulates  secretory  vesicles  and  arrests  as  a 
large unbudded cell with chitin randomly distributed on its 
surface (Johnston et al.,  1991).  Furthermore,  Myo2p con- 
centrates  at  sites  of cell  growth  (Lillie,  S.  H.,  and  S.  S. 
Brown. 1992. Mol. Biol. Cell. 3s:42a). Myo2p shares struc- 
tural features with an unconventional  myosin from vertebrate 
brain,  p190,  that  binds to  calmodulin in the  presence  of 
Ca  2÷  or  EGTA  (Espreafico  et  al.,  1992).  Like  the  brain 
protein,  Myo2p has six tandem repeats of a  Ca2+-indepen  - 
dent calmodulin-binding site (Johnston et ai.,  1991) known 
as an IQ site because its consensus sequence is IQXXXR- 
GXXXR (for review see Cheney and Mooseker,  1992). The 
calmodulin-binding  domains ofpl90 map precisely to the re- 
gion containing this motif (Espreafico et al.,  1992). 
Materials  and Methods 
Media and Strains 
Media for growth of S. cerevisiae and Escherichia coli are as described 
(Geiser et al., 1991; Davis, 1992). Genetic manipulations and yeast trans- 
formations were performed using standard techniques (Sherman et al., 
1986). The S.  cerevisiae strains are listed in Table I. Strains CRY1 and 
CRY2 (Davis, 1992) are derivatives of strain W303 (Wailis et al., 1989). 
All strains except strain JPTA are derived from strains CRY1 and CRY2. 
Strain JPTA (Johnston et ai., 1991) contains a temperature-sensitive muta- 
tion in the MY02 gene, myo2-66, and was kindly provided by G. Johnston 
(Dalhousie University, Halifax, Nova Scotia). In order to reduce heteroge- 
neity due to strain background differences, strain JPTA was backcrnssed 
four times with CRY strains to produce strain SBYS. SBY8 was sporulated 
and haploid progeny containing myo2-66 were identified by their inability 
to grow at 36"C. 
Strains containing mutant forms of caimodulin were constructed as fol- 
lows. Strain JGY41 (Geiser et al., 1991)  was crossed with strain EMY55-2A 
(Muller, E., unpublished results) to produce EMYS0. Strain EMYS0 was 
sporulated and strain EMY80-43C containing cmdl-3 was identified by its 
inability to grow at 37°C. The calmodulin gene, cmd/-3, encodes caimodu- 
lin with the  mutations D20A, E31V, D56A, E67V, D93A, and E104V 
(Geiser et al.,  1991). Strains JGY148, JGY149, JGY134, and BCY4 are 
CRY1 in which the wild-type calmodulin gene was replaced by the mutant 
caimodulin genes cmdl-5, cmdl-6, cradl-7, and cmdl-8 as described (Geiser 
et al., 1991). cmdl-5 encodes calmodulin with the mutations E31V, E67V, 
and E104V (3E~V). cmdl-6  encodes calmodulin with the mutations D20A, 
D56A, and D93A (3D-"A). The mutant calmodulin encoded by cmd/-7has 
isoleueine 27 changed to asparagine (I27N) and leueine 71 changed to argi- 
nine (L71R), cmdl-8 encodes calmodulin in which glycine in position 113 
is replaced with a valine (GI13V). 
Strain SBY21 containing a deletion of the SPA2 gene was constructed as 
follows. CRY1 was transformed with a 3.8-kb SaiI-HindI~ fragment from 
plasmid p210 (Gehrung and Snyder, 1990) and Ura  + transformants were 
selected. In plasmid p210, a 3,500-bp segment of SPA?. is replaced with the 
URA3 gene; the mutant SPA?. gene contains 39 codons of SPA?. upstream 
of URA3. The presence of the deletion was confirmed by Southern blot anal- 
ysis (data not shown). 
Plasmids 
Seven fusions of MY02 with glutathione S-transferase (GST)  1 were made 
using the GST Gene Fusion System (Pharmacia Diagnostics Inc., Fairfield, 
Table L  Yeast Strains 
Strain  Genotype  Reference 
i 
CRY1  MATa ade2-1oc canl-lO0 his3-11,15 Ieu2-3,112 trpl-1  ura3-1  R. Fuller (Stanford Uni- 
versity, Stanford, CA) 
MATa ade2-1oc canl-lO0 his3-11,15 leu2-3,112 trpl-1  ura3-1  R. Fuller 
MATc~ ade2-1oc ade3h-lO0 canl-lO0 cmdl-1  leu2-3,112 trpl-1  ura3-1  T.N.  Davis,  1992 
MATa ade2-1oc canl-lO0 cmdl-3 his3-11,15 1eu2-3,112 trpl-1  ura3-1  J.R.  Geiser et al.,  1991 
MATa adel his6 1eu2-3,112 ura3-52 myo2-66  G.C. Johnston, 1991 
MATc~ ade2-1oc ade3h-lO0  canl-lO0 cyh2' his3-11,15 1eu2-3,112  E. Muller (University of 
lys2  A :  :  HIS3 trp  l-1 trx  l A :  :  TRP1 ura3-1  Washington, Seattle,  WA) 
EMY55-2A X JGY41  E. Muller 
MATa ade2-1oc ade3h-lO0  canl-lO0  cmdl-3 his3-11,15 1eu2-3,112  E. Muller 
lys2h :  :HIS3 trp  l-1 ura3-1 
MATa ade2-1oc canl-lO0  cmdl-7 his3-11,15 Ieu2-3,112 trpl-1  ura3-1 
MATa ade2-1oc canl-lO0  cmdl-5 his3-11,15 Ieu2-3,112 trp  l-1 ura3-1 
MATa ade2-1oc canl-lO0 cmdl-6 his3-11,15 1eu2-3,112 trp  l-1 ura3-1 
MA Ta ade2-1oc can  l-  l O0 cmd  l-8 his3-11,15 1eu2-3,112 trp  l-1 ura3-1 
MATa ade2-1oc canl-lO0 his- 1eu2-3,112 myo2-66 ura3- 
MATa ade2-1oc canl-lO0  his- leu2-3,112 myo2-66 ura3- 
TDY62-13A X SBY8-6A 
SBY8-5A  X EMY80-43C 
SBY8-5A  X JGY134 
MATa ade2-1oc canl-lO0  cmdl-7 his- 1eu2-3,112 myo2-66 ura3- 
MATa ade2-1oc canl-lO0  cmdl-7 his- 1eu2-3,112 myo2-66 trpl-1  ura3- 
SBYS-5A X JGY148 
SBY8-5A X JGY149 
SBY8-5A X BCY4 
MATa ade2-1oc canl-lO0 his3-11,15 leu2-3,112 spa2h  :  :URA3 trpl-1  ura3-1 
TDY62-13A X SBY21 
MATa ade2-1oc ade3h-lO0 canl-lO0  cmdl-1 his3-11,15 1eu2-3,112 
spa2A :  :URA3 trp  l-1 ura3-1 
CRY2 
TDY62-13A 
JGY41 
JP7A 
EMY55-2A 
EMY80 
EMY80-43C 
JGY134 
JGY148 
JGY149 
BCY4 
SBY8-5A 
SBYS-6A 
SBY 11 
SBY13 
SBY14 
SBY14-19A 
SBY14-20C 
SBY15 
SBY16 
SBY17 
SBY21 
SBY23 
SBY23-2A 
J.  R. Geiser (University of 
Washington, Seattle,  WA) 
J.  R. Geiser 
J.  R. Geiser 
B. Chang (University of 
Washington, Seattle,  WA) 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
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(Johnston et al.,  1991). 
In  plasmid  pSB20,  the  nucleotides  encoding  amino  acid  residues 
740-1,457  of Myo2p  were  fused in frame to GST by ligating  the 2.1-kb 
EcoRV fragment of MY02, into the SmaI site of pGEX-3X (Pharmacia Di- 
agnostics  Inc.).  Plasmid pSB21 contains the l.l-kb EcoRV-EcoRI MY02 
fragment fused in frame to GST in plasmid pGEX-3X and was constructed 
by digesting pSB20 with EcoRI and then religating. The EcoRV-EcoRI frag- 
ment encodes residues  740-1,116 of Myo2p.  To create the next construct, 
plasmid pSB21, grown in a dam- E.  coli strain GM2163  (NEB), was lin- 
earized with EcoRI and then partially digested with Bell. A 5.4-kb fragment 
obtained from the partial digestion was gel purified, treated with the large 
fragment of E.  coli DNA polymerase in the presence of dNTPs, and then 
religated.  The resulting plasmid, pSB23, contains a 0,5-kb EcoRV-BclI 
fragment encoding amino acid residues 740-912 of Myo2p. Plasmid pSB24 
contains a 0.4-kb fragment of MY02 encoding residues  790-924 fused in 
frame to GST in pGEX-3X.  This MY02 fragment was obtained using PCR. 
The primers used were: 
SB-3: 5'-GCTCGGATCCAGAAGAAAATTAGAGCTAAATATTAC-3' 
and 
SB-4: 5'-CGCGGATCCTTTCAATTTCCTTTGAGCAGCTCTTCT-3'. 
Each primer contains a BamHI site (GGATCC) near the 5' end to facilitate 
subcloning.  Approximately  1 ng of linearized plasmid pJPI0-2B was used 
in each 50 #1 PCR. The final concentration of each primer was 1/~M. Re- 
agents for PCR were supplied by Gene-Amp PCR reagent kit (Perkin-Elmer 
Cetus, Norwalk,  CT). After amplification,  four-fifths of the reaction was 
run on a 1% agarose gel and purified.  The purified MY02 fragment was then 
digested with BamHI and ligated into the BamHI site of plasmid pGEX-3X. 
Plasmid pSB25 was constructed by first digesting pSB21 with EcoRV and 
PvulI and religating to create plasmid pSB21A. Plasmid pSB21A was then 
digested with HpaI and EcoRI, treated with the large fragment of E.  coli 
DNA polymerase in the presence of dNTPs, and then religated. The result- 
ing plasmid, pSB25, contains a 279-bp EcoRV-HpaI MY02 fragment fused 
in frame to  GST.  The  EcoRV-HpaI  MY02  fragment encodes residues 
740-833.  Plasmid pSB26 was constructed by digesting  plasmid pSB21A 
with EcoRI and NsiI and then religating. Plasmid pSB26 contains a 129-bp 
MY02 fragment encoding residues 740-782.  Finally, in plasmid pSB27, the 
nucleotides encoding amino acid residues 247-740 of Myo2p were fused in 
frame to GST by ligating a 1.5-kb BamHI-ECORV fragment of MY02 into 
the BamHI-SmaI sites of plasmid pGEX-3X. 
Plasmid pJG58 is a derivative of plasmid YEp24 and was constructed by 
replacing  the BamHI-SalI fragment of pTD17 (Zhu et al.,  1993) with a 
BamHI-SalI fragment containing cmdl-3 from plasmid pJG27 (Geiser et al., 
1991). 
Fusion Protein Expression 
E. coli strain GM1 (Coulondre and Miller,  1977) containing either plasmid 
pGEX-3X,  pSB20, pSB21, pSB23, pSB24, pSB25, pSB26, or pSB27 was 
grown in LB medium containing 100 #g/ml ampicillin. At approximately 
15 Klett units (7.5  x  107 cells/ml), isopropyl-#-o-thiogalactopyranoside 
was added to a final concentration of 2 raM. At 80 Klett units, cultures were 
harvested by centrifugation and then resuspended in 1/100 volume "crack- 
ing" buffer containing 0.01 M  sodium phosphate, pH 7.2,  1% /~-mercap- 
toethanol, 1% SDS, and 6 M urea. Although growth to higher densities was 
possible, the amount of fusion protein obtained was significantly  reduced 
in denser cultures.  After incubation for 30 rain at 370C in cracking buffer, 
one volume 2x  Laemmli sample buffer was added.  SDS-polyacrylamide 
gel electrophoresis was done as described (Brockerhoff et al.,  1992). The 
acrylamide concentration was 11% and the ratio of acrylamide to bisacryl- 
amide was 39:1. Approximately  30/.tg total protein was loaded in each lane. 
The gel overlay assay for calmodulin-binding  proteins was performed as de- 
scribed (Brockerhoffet al., 1992) with the following changes. After transfer 
to the Immobilon membrane, proteins were renatured by washing for 30 min 
(three changes)  in 20 mM Hepes,  pH 7.2,  and then the membrane was 
blocked overnight in 20 mM Hepes, pH 7.2, with 0.05% Tween-20 and 3% 
BSA. Membranes were probed for 1-2 h in 20 mM Hepes, pH 7.2, 10 mM 
NaCI,  0.1% BSA containing either 1 mM EGTA or  1 mM CaCI2, and 
80 nM 35S-labeled wild-type calmodulin. 
1. Abbreviations used in this paper: GST, glutathione S-transferase;  ts, tem- 
perature sensitive. 
Extraction of  Myo2p and Immunoprecipitation 
Myo2p was extracted from yeast cells in a buffer containing 0.5 M NaC1 
as follows. A 200-ml yeast culture was grown in YPD (Geiser et al.,  1991) 
at 30"C to 150 Klett units (3  x  107 cells/ml). Cells were harvested and 
washed once with buffer A (50 mM Tris,  pH 7.5, and protease inhibitor 
cocktail [Drubin et al.,  1988]) and then resuspended in an equal volume 
of buffer A. Cells were lysed in the presence of one volume glass beads in 
a plastic tube by mixing five times for 1 rain on a vortex mixer. Myo2p is 
insoluble in buffer A and was collected by centrifugation for 15 min at 4°C 
in a microfuge (Fisher model 235C, Pittsburgh, PA). The pellet was washed 
once with 0.7 ml buffer A. Then "~50% of the Myo2p was extracted with 
buffer A containing 0.5 M NaC1. The sample was incubated on ice for 5 
min, and insoluble debris was removed by centrifugation in the microfuge 
at 4°C for 15 min. If the extracts were prepared in glass tubes or in a bead 
beater, the yield of Myo2p was dramatically decreased.  CaCI2 (5 mM) or 
EGTA (1 raM) was added to the supernatants.  Approximately  250/tg total 
protein (100/~1 of the high-salt supernatant) was incubated with an aliquot 
(10 #1) of anti-calmodulin  antiserum, affinity-purified anti-calmodulin anti- 
body, or preimmune serum from the same rabbit for 60 rain on ice. An ali- 
quot (50 #1) of pansorbin cells (Calbiochem Novabiochem,  Corp., La Jolla, 
CA) was added to each sample and the incubation continued for 60 min. 
After centrifugation in the microfuge  at 40C  for 2 min, the pellets were 
washed once with  100  /zl  buffer  A  containing 0.5  M  NaC1 and then 
resuspended in 30/zl Laemmli buffer. The supernatants were precipitated 
with trichloroacetic acid and resuspended in Laemmli sample buffer (30 #1). 
Samples  were boiled for 3 min before SDS-gel electrophoresis. 
Antibodies and Immunoblot Analysis 
The  calmodulin  antiserum  and  antibodies  were  described  previously 
(Brockerhoff and  Davis,  1992).  The anti-Myo2p antibody was  affinity 
purified  as described (Lillie  and Brown,  1987) using a/~-galactosidase- 
Myo2p fusion protein immobilized on nitrocellulose.  Immobilized fusion 
protein and anti-M~x)2p  antiserum (prepared against an anthranflate synthase- 
Myo2p fusion) was kindly provided by S. Brown and S. Lillie (University 
of Michigan, Ann Arbor, MI). Extensive experiments establishing  the spec- 
ificity  of the anti-Myo2p antibody will  be presented elsewhere (Lillie, 
S. H., and S.  S. Brown,  manuscript in preparation). 
Immunoblot analysis was done using ECL reagents (Amersham Corp., 
Arlington Heights, IL) as described (Geiser et al., 1991) with the following 
exceptions.  For detection of calmodulin, the membrane was incubated with 
a 1:2,000 dilution of anti-calmodulin serum overnight and subsequently in- 
cnhated with a  1:5,000 dilution of goat anti-rabbit IgG conjugated  with 
horseradish peroxidase.  For analysis of Myo2p, the acrylamide concentra- 
tion in the gel was 6% and the ratio of acrylamide to bisacrylamide was 
39:1. The membrane was incubated with a 1:100 dilution of afffinity-purified 
anti-Myo2p antibody overnight. 
Genetic Analysis 
Six  different  alleles of CMD1  were  tested for their interaction with the 
temperature-sensitive allele  myo2-66  by  comparing the  phenotypes  of 
strains containing mutations in both CMD1 and MY02 to the phenotype of 
strains containing mutations in either MY02 or CMD1.  We obtained the 
double mutant strains by crossing a strain containing a mutant calmodulin, 
with a strain containing myo2-66 (Ihble I) and then sporulating the hetero- 
zygous diploid. We determined whether a spore had one or both single mu- 
tations by examining spore growth at 21, 25, 30, 32, 34, and 37"C (Table 
II).  We concluded that the double mutant phenotype was the same as the 
more severe single mutant when >90 % of the tetrads had four viable spores, 
none of which died at a lower temperature than the parent strains.  In this 
case a parental ditype (PD) had four temperature-sensitive (ts) spores,  a 
tetratype (TT) had three ts spores and one wild-type,  and a nonparental di- 
type (NPD) had two ts spores and two wild-type spores. We concluded that 
the double mutant was inviable at room temperature if many tetrads had 
only two or three viable spores and 0/2 (NPD) or 2/3 (TT) spores were tem- 
perature sensitive. 
Results 
Calmodulin and Myo2p Have Similar Distributions 
Lillie and Brown  (1992,  Mol. Biol. Cell. 3s:42a) demon- 
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CMD1  and myo2-66 
Death  Death 
CaM  temperature  temperature 
mutations  (cmdl alone)  (cmdl, myo2-66) 
°C  °C 
None  39-40  32 
(CMD1) 
I100N,  E104V  32  <21 
(cmdl-1) 
127N,  L71R  37  30 
(  cmd  l- 7) 
G113V  38  <21 
(  cmd1-8) 
3E-"V,3D~A  37  30 
(  cmd1-3) 
3E~V  39-40  30 
(cmd1-5) 
3D--'A  39-40  32 
(cmdl-6) 
Strains containing only myo2-66 are dead at 32°C (top row). 
strated that Myo2p localizes at sites of cell growth through- 
out the  cell cycle.  We did a  side by side comparison of 
Myo2p and calmodulin and found that the distribution of the 
two proteins is nearly identical (Fig. I). Unbudded cells con- 
tained a  patch of Myo2p. Small budded cells had Myo2p 
throughout the bud. Medium budded cells had Myo2p con- 
centrated more towards the bud tip, and large budded ceils 
had Myo2p concentrated in the neck region between mother 
and bud (Fig. 1). Furthermore, the region containing Myo2p 
was  similar in size to the region containing calmodulin. 
These results are consistent with calmodulin and Myo2p in- 
teracting at sites of cell growth. Two minor differences in the 
distributions were observed. Calmodulin appeared more dif- 
fusely distributed throughout the cell than Myo2p and the 
mother cell was more brightly stained with calmodulin anti- 
body than with Myo2p antibody consistent with calmodulin 
being required in processes in addition to polarized growth 
(Davis,  1992). 
CMD1 Interacts Genetically with MY02 
but not with SPA2 
Next, we used genetic methods to determine if CMD1 and 
MY02 interact. We compared the phenotype of strains con- 
taining mutations in both CMD1 and MY02 to the phenotype 
of strains containing mutations in either CMD1 or MY02. 
The  phenotype  of some  strains  containing  temperature- 
sensitive mutations in both CMD1 and MY02 is more severe 
than the phenotype of strains carrying either mutation alone. 
The  severity of the  double  mutant phenotype varies  for 
different calmodulin alleles (Table II). 
cmdl-1 was the first temperature-sensitive calmodulin al- 
lele isolated and is the best characterized. Strains containing 
cmdl-1  show  a  delay in  bud emergence and bud  growth 
(Davis,  1992). A strain containing both cmdM and myo2-66 
was inviable at room temperature.  Thus a  CMD1 mutant 
known to show a defect in polarized growth is inviable when 
combined with myo2-66. 
Two less characterized CMD1 mutants, cmdl-7 and cmdl-8, 
also  show  a  genetic  interaction with myo2-66.  Although 
strains  containing only cmdl-7 or only myo2-66 grew  at 
30°C, the double-mutant strain containing both of these mu- 
tations did not grow at this temperature (Fig. 2). A more se- 
vere interaction was detected between the mutations cmdl-8 
and myo2-66.  Strains containing these two mutations were 
inviable at room temperature (21°C).  Interestingly, strains 
containing only cmdl-7or cmdl-8 were inviable at nearly the 
same temperatures,  37  and 38°C,  respectively.  Thus, the 
severity of the double mutant phenotype does not correlate 
with the severity of the temperature-sensitive phenotype of 
a  calmodulin mutant;  strains containing both cmdl-7 and 
myo2-66 or both cmdl-8 and myo2-66 died at significantly 
different temperatures while strains containing only cmdl-7 
or cmdl-8 died at approximately the same temperature. 
To  examine  the  interaction  between  calmodulin  and 
Myo2p in more detail we examined the terminal morphology 
of a strain containing both cmdl-7 and myo2-66 after incuba- 
tion at its nonpermissive temperature, 30°C. At this temper- 
ature, the double mutant strain accumulated large unbudded 
cells (data not shown). This terminal phenotype resembled 
that of the parent strain containing only myo2-66 when in- 
cubated at 32°C or higher (Johnston et al.,  1991; data not 
shown). In contrast, at 37°C or above, the terminal morphol- 
ogy of  the strain containing only cmdl-7is heterogeneous (B. 
Chang, University of Washington, Seattle, WA, unpublished 
result). Thus mutations in calmodulin exacerbate the defect 
associated with a loss of Myo2p function. 
Previously we demonstrated that strains containing mu- 
tant forms of calmodulin defective in binding Ca  2÷ grew at 
the same rate as  strains containing wild-type calmodulin 
(Geiser  et  al.,  1991). Furthermore,  the  distributions  of 
calmodulin containing the mutations 3D~A or 3E--'V (see 
Materials  and Methods)  were  indistinguishable from the 
wild-type protein (Brockerhoff and Davis, 1992).  Although 
the affinity of these mutant proteins for Ca  2÷ is decreased 
more than 100-fold,  strains relying on the mutant calmodu- 
lins grow buds at the same rate as wild-type cells. As ex- 
pected,  the  genes  encoding  3D--'A  (cmd/-6)  and  3E~V 
(cmd/-5) calmodulin displayed little interaction with myo2- 
66. Growth of strains with cmdl-6 and myo2-66 was indistin- 
guishable at all temperatures from the growth of strains car- 
rying myo2-66 alone. The presence of cmdl-5 decreased the 
death temperature ofmyo2-66 strains by only 20C (Table II). 
A calmodulin gene with six mutations in the Ca2+-binding 
sites,  cmdl-3,  also decreased the death temperature by 2°C 
(Table  II), but even at 21°C,  strains carrying cmdl-3 and 
myo2-66 grew very slowly. The negative interaction between 
cmdl-3 and myo2-66 is largely explained by the low level of 
calmodulin produced by the cmdl-3 allele (27 % of the wild- 
type level) because extra copies of cmdl-3 on a multi-copy 
plasmid, pJG58,  allows the double mutant carrying cmdl-3 
and myo2-66 to grow well up to 30°C. 
In contrast to our results suggesting an interaction between 
calmodulin and Myo2p, several  results suggest calmodulin 
does not interact with Spa2p,  another protein found at sites 
of cell growth (Snyder,  1989;  Gehrung and Snyder,  1990; 
Snyder et al., 1991). First, a double-mutant strain containing 
a deletion of SPA2 and cmdM had the same phenotype as a 
strain containing cmdM  alone,  indicating that SPA2 and 
CMD1 do not interact genetically. Second, we performed a 
side by side comparison of cells stained with anti-Spa2p (gift 
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localization  of  Myo2p  and 
calmodulin  (CAM).  Cells 
were  stained  with  affinity- 
purified anti-yeast calmodulin 
antibody as described (Brock- 
erhoff and Davis, 1992). The 
procedure to stain cells with 
anti-Myo2p antibody was the 
same as with anti-calmodulin 
antibody except ceils were in- 
cubated  with a  25-fold dilu- 
tion  of  antibody  overnight. 
Affinity-purified  anti-Myo2p 
antibody was kindly provided 
by S. Brown and S. Liilie. 
of M.  Snyder,  Yale  University, New Haven,  CT) to cells 
stained with anti-calmodulin and found that the distributions 
of the two proteins are  similar but distinct.  Spa2p  is  ex- 
clusively localized at the bud tip, whereas calmodulin and 
Myo2p are more diffuse (data not shown). 
Calmodulin Associates with Native Myo2p 
The immunocytochemistry and the genetic analysis suggest 
that Myo2p and calmodulin interact at sites of cell growth 
and that the interaction does not depend on a high affinity 
for Ca  2÷. To obtain direct evidence for a molecular complex 
between calmodulin and Myo2p in yeast extracts, we analyzed 
calmodulin immune complexes for the presence of Myo2p. 
First we developed a method to solubilize yeast Myo2p using 
high salt (see Materials and Methods). Then the crude yeast 
extract containing solubilized Myo2p was immunoprecipi- 
tated with anti-calmodulin antiserum, afffinity-purified anti- 
calmodulin antibody, or preimmune serum from the same 
rabbit. In 9 of 11 experiments, anti-calmodulin antiserum re- 
covered Myo2p whereas the preimmune serum did not (Fig. 
3). The recovery of Myo2p did not depend on the presence 
of Ca  2+ since Myo2p was also precipitated when EGTA was 
present (Fig.  3).  Furthermore, precipitation of calmodulin 
with affinity-purified antibody also recovered Myo2p (Fig. 
Brockerhoff et al.  Calmodulin Binds Myo2p at Sites of Cell Growth  319 Figure 2.  Growth of yeast strains containing cmdl-7, myo2-66, or both mutations.  Strain JG'YI34 (cmd/-7),  strain SBYg-SA (myo2-66), 
strain SBY14-19A (cmd/-7, myo2-66), and strain SBYI4-20C (cmdl-7, myo2-66) were plated onto YPD plates and incubated at the indicated 
temperatures  for 4 d.  JGY134 (cmd/-7) is temperature-sensitive  for growth at 37°C, 
3).  In two experiments Myo2p was not precipitated for un- 
known reasons. As an additional control for the specificity 
of the antibody, we demonstrated that anti-yeast calmodulin 
antibody does not recover Myo2p from a yeast strain express- 
ing vertebrate calmodulin instead of yeast calmodulin (data 
not shown). (We have shown previously that our anti-calmod- 
ulin antiserum does not cross-react with vertebrate calmed- 
ulin [Brockerhoff and Davis,  1992]).  These results demon- 
strate that  calmodulin  and  Myo2p  can  form a  molecular 
complex in 0.5 M  NaCl, in the presence of Ca  2÷ or EGTA. 
Calmodulin Interacts with Myo2p In Vitro 
We used a  modified gel overlay assay (Brockerhoff et al., 
1992) to determine whether yeast calmodulin directly binds 
to the six putative IQ type calmodulin-binding sites in Myo2p. 
In this assay proteins are subjected to electrophoresis on an 
SDS gel and transferred to a membrane. The membrane is 
then washed to remove SDS and probed with radiolabeled 
calmodulin. 
Portions of Myo2p were expressed in E.  coli as a  fusion 
with GST.  The six IQ sites extend from residue 790-940. 
Seven different fusions  containing  portions  of Myo2p ex- 
tending from residue 247-1,457  were constructed (see Fig. 
4). (Full-length Myo2p contains 1,574 residues.) The fusion 
proteins exhibited electrophoretic mobilities on SDS-PAGE 
consistent with their predicted size (Fig.  5 A). Calmodulin 
binding was mapped precisely to the residues between 790 
and 940 (Fig. 5, B and C). Furthermore, fusions containing 
all six IQ sites interacted well with yeast calmodulin in either 
Figure 3. Immunoprecipitation with anti-calmodulin antisera. Yeast 
extracts containing  solubilized Myo2p were incubated with anti- 
calmodulin antiserum (lanes 1 and 2), affinity-purified  anti-calmod- 
ulin antibodies (lanes 3 and 4) or preimmune antiserum (lane 5 and 
6). Immunoprecipitations were performed in the presence of EGTA 
as described  in Materials  and Methods.  Supernatants  (lanes 1, 3, 
and 5) and precipitates (lanes 2, 4, and 6) were examined by anti- 
Myo2p (A) or anti-calmodulin  (B)  immunoblots as described  in 
Materials  and Methods. 
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Figure 4. Myo2p fusion proteins. Plasmid construction is described 
in Materials and Methods. The indicated restriction sites were used 
for cloning. These sites are not necessarily unique (Johnston et al., 
1991). 
the presence of Ca  2+ (Fig.  5 B) or EGTA (Fig.  5  C).  We 
judged that the interaction between calmodulin and the vari- 
ous fusions was specific since other abundant proteins such 
as GST (lane/), and fusions containing Myo2p fragments 
lacking the IQ sites (lanes 3 and 8), did not bind to calmodu- 
lin. Two IQ sites (lane 7) are sufficient for calmodulin bind- 
ing but unlike fusions containing all six IQ sites (lanes 2, 4, 
and 6), the fusion containing two sites bound significantly 
better in the presence of EGTA than in the presence of Ca  2+ 
(compare lane 7 in 5, B and C). 
Discussion 
The following results suggest that calmodulin participates in 
polarized cell growth by regulating Myo2p through a direct 
interaction. First, we detect a specific genetic interaction be- 
tween CMD1 and MY02. Second, the localization of Myo2p 
and calmodulin are nearly indistinguishable. Third, calmod- 
ulin and Myo2p associate in yeast extracts. Finally, calmodu- 
lin binds specifically to the IQ sites of Myo2p in the presence 
of Ca  2+ or EGTA in a modified gel overlay assay. 
Myo2p is a recently identified member of the class V fam- 
ily of unconventional myosins (Johnston et al.,  1991;  Es- 
preafico et al., 1992). The other members include p190 from 
vertebrate brain (Espreafico et al., 1992), dilute from mouse 
(Mercer et al.,  1991), and Myo4p from yeast (EMBL/Gen- 
bank/DDBJ accession number M90057). With the exception 
of p190, members of this class have not been biochemically 
characterized, p190 is a calmodulin-binding protein associ- 
Figure 5. Identification of  the IQ sites as the calmodulin-binding re- 
gion of Myo2p. Fusion proteins were expressed and subjected to 
SDS-polyacrylamide gel electrophoresis as described in Materials 
and Methods. SDS gel stained with Coomassie blue R250 (A). The 
full-length fusion protein in each extract is marked by an arrow. Au- 
toradiographs of membranes incubated with 35S-labeled  calmodu- 
lin in the presence of Ca  2+ (B) or EGTA (C). The gel overlay as- 
say was performed as described in Materials and Methods. Lanes 
1-8 contain  extracts of E.  coli  strain GM-1 containing plasmid 
pGEX-3X, pSB20, pSB27, pSB21, pSB23, pSB24,  pSB25, and 
pSB26, respectively (see Fig. 4). 
ated with the actin-based cytoskeleton in brain. It is a phos- 
phorylation  substrate  for calmodulin-dependent kinase  H 
and has Mg2+-ATPase activity that is stimulated severalfold 
by the addition of Ca  2+ (Larson et al.,  1990; Espindola et 
al., 1992). Calmodulin binds tightly to p190 and remains as- 
sociated during gel filtration chromatography in the pres- 
ence  of Ca  2+  or  EGTA  (Larson  et  al.,  1988).  Besides 
calmodulin, no other polypeptides in the  16-20-kD range 
remain associated with p190 (Espindola et al.,  1992). Cal- 
modulin also interacts with chicken brush border myosin I, 
a  member of a  different class  of unconventional myosins 
(Mooseker et al., 1991). Since myosin light chains are mem- 
bers  of the  calmodulin/EF-hand  superfamily,  calmodulin 
may serve as regulatory light chains for a subclass of uncon- 
ventional myosins (Cheney and Mooseker, 1992; Espreafico 
et al.,  1992). 
The site proposed to function as the light chain binding 
site in conventional and unconventional myosins is referred 
to  as  an  IQ  site  and  has  the  conserved  core  sequence 
IQXXXRGXXXR. All myosins contain one or more IQ sites 
(Cheney and Mooseker,  1992).  The site of interaction of 
p190 with calmodulin has been precisely mapped to a region 
containing six imperfect tandem repeats of this motif (Es- 
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the region of  brush border myosin I implicated in calmodulin 
binding  (Carboni  et  al.,  1988;  Coluccio  and  Bretscher, 
1988; Cheney and Mooseker, 1992). Like p190, Myo2p has 
six IQ repeats (Johnston et al., 1991). In this study we dem- 
onstrate that calmodulin associates with Myo2p and that the 
calmodulin-binding site in Myo2p maps exactly to the region 
containing the six IQ repeats. To determine if the combined 
presence of all sites is necessary for calmodulin binding, we 
constructed a fusion containing only the first two IQ sites. 
This two-site fusion protein also interacted with calmodulin 
indicating that at least one of the first two sites is active in 
binding calmodulin. The functional significance of several 
tandemly repeated calmodulin-binding sites in unconven- 
tional myosins is unclear. Using the genetic techniques avail- 
able in S. cerevisiae we can now begin to mutate and delete 
the IQ sites in vivo to determine the role of each IQ site in 
polarized growth. 
Calmodulin associates  with  Myo2p in  the presence  of 
Ca  2+  or EGTA both in  solution and in an overlay assay. 
Since  most calmodulin-binding proteins bind  calmodulin 
only in the presence of Ca  2+ (Cohen and Klee,  1988) this 
Ca2+-independent association suggests a unique mechanism 
of regulation. One proposal, based on studies with p190, is 
that calmodulin associates with p190  irrespective of Ca  2÷ 
and allosterically regulates ATPase activity through Ca  2÷- 
dependent conformational changes. This hypothesis is based 
on the finding that the addition of Ca2+-calmodulin  stimu- 
lates the ATPase activity of p190  to a  greater extent than 
Ca  :+ alone (Larson et al., 1990; Espindola et al., 1992). In 
contrast, our results in yeast indicate that Ca  :+ binding to 
calmodulin is not needed for normal bud growth. Mutant 
calmodulins defective in binding Ca  2+ properly localize to 
sites of cell growth and strains relying on these mutant pro- 
teins do not show growth defects (Geiser et al., 1991; Brock- 
erhoff and Davis, 1992).  The results of the genetic analysis 
are also consistent with the idea that the ability of calmodulin 
to interact with or regulate Myo2p is not dependent on a high 
affinity for Ca  2÷. Mutations in CMD1 that abolish the abil- 
ity of calmodulin to bind Ca  2+ have little or no effect on 
strains carrying the temperature-sensitive mutation, myo2- 
66. In contrast, a severe negative interaction was observed 
between myo2-66 and the allele cmdl-8 with a mutation out- 
side the Ca2+-binding sites. 
Calmodulin binding to Myo2p could be regulated by phos- 
phorylation as has been proposed for other Ca2÷-indepen  - 
dent calmodulin-binding proteins such as the neuron-specific 
protein kinase C substrates,  neuromodulin, and neurogranin. 
Both proteins contain a protein kinase C phosphorylation site 
within an IQ type calmodulin-binding site. Protein kinase C 
phosphorylation of neuromodulin at serine 41 disrupts cal- 
modulin binding to the IQ site (Apel et al., 1990; Chapman 
et al., 1991). A mutational analysis indicated that the muta- 
tion S41D also disrupts calmodulin binding. Thus binding of 
calmodulin to the IQ site of neuromodulin is regulated by the 
introduction of a  negative charge within this region.  Sig- 
nificantly, a  putative  p34  °oc: phosphorylation site  resides 
near the IQ sites in Myo2p (Johnston et al., 1991). Alterna- 
tively, in a manner analogous to the phosphorylation of myo- 
sin fight chains, modification of calmodulin rather than Myo2p 
may regulate the association between calmodulin and Myo2p. 
Myo2p, p190, and dilute  are all implicated in polarized 
vesicle movement. Immunolocalization studies on p190 and 
Myo2p and the phenotypes of mutant myo2 and dilute alleles 
are consistent with a role for class V myosins in vesicle trans- 
port (Silvers,  1979;  Johnston et al.,  1991; Mercer et al., 
1991; Espreafico et al., 1992; Lillie, S. H., and S. S. Brown. 
1992. Mol. Biol.  Cell. 3s:42a). Here we demonstrate a spe- 
cific genetic and biochemical interaction between calmodulin 
and Myo2p. Future studies will use the genetic techniques 
available in yeast to define the role of calmodulin, Ca  :+ and 
phosphorylation in regulating Myo2p function in polarized 
growth. 
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